US Defense Lab Selects Third Wave Reagents for CF Screening | GenomeWeb

NEW YORK, Dec 9 (GenomeWeb News) - The US Armed Forces Institute of Pathology (AFIP) - the central reference laboratory for the Army, Navy, Air Force, Public Health Service, and Department of Veterans Affairs - has selected Third Wave Technologies' Invader analyte-specific reagents for cystic fibrosis (CF) genetic screening, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.